Advertisement

Exkurs: Affektive Störungen bei Morbus Parkinson

  • K. W. Lange
  • G. Becker
  • T. Becker
Chapter

Zusammenfassung

Parkinsonpatienten leiden häufig unter affektiven Störungen, vor allem unter Depression und Angst (Schiffer et al. 1988, Stein et al. 1990). Die in der Literatur beschriebenen Prävalenzraten für das Vorliegen einer Depression bei der Parkinsonkrankheit reichen von vier bis 90% bei einer mittleren Häufigkeit von etwa 40–50% (Levin et al. 1988, Cummings 1992). Depressive Parkinsonpatienten haben einen verminderten Antrieb, sind wegen ihrer Gesundheit besorgt, äußern somatische Beschwerden, sind pessimistisch und betrachten ihre Lage oft als aussichtslos. Suizidgedanken kommen bei Parkinsonkranken vor, Suizide sind jedoch selten. Depression wird zuweilen bereits vor der Parkinsondiagnose beobachtet, tritt häufig etwa zum Zeitpunkt der Diagnosestellung auf und erscheint bei einer Reihe von Parkinsonpatienten erst im weiteren Verlauf der Krankheit.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alexander GE, De Long MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: 357–381PubMedCrossRefGoogle Scholar
  2. Azmitia EC, Gannon P (1985) The serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. In: Fahn S (ed) Myoclonus. Raven Press, New YorkGoogle Scholar
  3. Baxter LR, Schwartz JM, Phelps ME et al. (1989) Reduction of pre-frontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46: 243–250PubMedCrossRefGoogle Scholar
  4. Becker G, Struck M, Bogdahn U, Becker T (1994) Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res Neuroimaging 55: 75–84CrossRefGoogle Scholar
  5. Becker G, Becker T, Struck M, Lindner A, Burzer K, Retz W, Bogdahn U, Beckmann H (1995) Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 38: 180–184PubMedCrossRefGoogle Scholar
  6. Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, Lindner A, Reichmann H, Riederer P, Beckmann H, Reiners K (1997) Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63: 590–596PubMedCrossRefGoogle Scholar
  7. Bench CJ, Friston KJ, Brown RG et al. (1992) The anatomy of melancholia — focal abnormalities of cerebral blood flow in major depression and the cognitive impairment of depression. Psychol Med 22: 607–615PubMedCrossRefGoogle Scholar
  8. Cantello R, Gilli M, Riccio A, Bergamasco B (1986) Mood changes associated with „end-of-dose deterioration“ in Parkinson’s disease: a controlled study. J Neurol Neurosurg Psychiatry 49: 1182–1192PubMedCrossRefGoogle Scholar
  9. Cantello R, Aguggia M, Gilli M et al. (1989) Major depression in Parkinson’s disease and the mood response to intravenous methyphenidate: possible role of the „hedonic“ dopamine system. J Neurol Neurosurg Psychiatry 52: 724–731PubMedCrossRefGoogle Scholar
  10. Celesia GG, Wanamaker WM (1972) Psychiatric disturbances in Parkinson’s disease. Dis Nerv Syst 33: 577–583PubMedGoogle Scholar
  11. Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson’s disease with and without dementia and depression. J Comp Neurol 287: 373–392PubMedCrossRefGoogle Scholar
  12. Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149: 443–457PubMedGoogle Scholar
  13. Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ (1990) Depressive symptoms in Parkinson’s disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol 2: 3–9CrossRefGoogle Scholar
  14. Garver DL, Davis JM (1979) Biogenic amine hypothesis of affective disorders. Life Sci 24: 383–394PubMedCrossRefGoogle Scholar
  15. Gotham A-M, Brown RG, Marsden CD (1986) Depression in Parkinson’s disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49: 381–389PubMedCrossRefGoogle Scholar
  16. Hoehn M, Crowley TJ, Rutledge CO (1976) Dopamine correlates of neurological and psychological status in untreated parkinsonism. J Neurol Neurosurg Psychiatry 39: 941–951PubMedCrossRefGoogle Scholar
  17. Horn S (1960) Some psychological factors in parkinsonism. J Neurol Neurosurg Psychiatry 23: 56–61CrossRefGoogle Scholar
  18. Huber SJ, Paulson GW, Shuttleworth EC (1988) Relationship of motor symptoms, intellectual impairment, and depression in Parkinson’s disease. J Neurol Neurosurg Psychiatry 51: 855–858PubMedCrossRefGoogle Scholar
  19. Jellinger K (1986) Overview of morphological changes in Parkinson’s disease. In: Yahr MD, Bergmann KJ (eds) Advances in neurology: Parkinson’s disease. Raven Press, New York, pp 1–19Google Scholar
  20. Kearney TR (1964) Parkinson’s disease presenting as a depressive illness. J Irish Med Assoc 54: 117–119Google Scholar
  21. Kostic VS, Djuricic BM, Covickovic-Sternis N et al. (1987) Depression and Parkinson’s disease: possible role of serotonergic mechnisms. J Neurol 234: 94–96PubMedCrossRefGoogle Scholar
  22. Laplane D, Levasseur M, Pillon B et al. (1989) Obsessive-compulsive and other behavioral changes with bilateral basal ganglia lesions. Brain 112: 699–725PubMedCrossRefGoogle Scholar
  23. Levin BE, Llabre MM, Weiner WJ (1988) Parkinson’s disease and depression: psychomeric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry 51: 140–144Google Scholar
  24. Lloyd KJ, Farley IJ, Deck JHN, Hornykiewicz O (1974) Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients. Adv Bio-chem Psychopharmacol 11: 387–397Google Scholar
  25. Loranger AW, Goodel H, Lee JE et al. (1972) Intellectual impairment in Parkinson’s syndrom. Brain 95: 405–412PubMedCrossRefGoogle Scholar
  26. Marsh GG, Markham CH (1973) Does levodopa alter depression and psychopathology in parkinsonism patient? J Neurol Neurosurg Psychiatry 36: 925–935PubMedCrossRefGoogle Scholar
  27. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrczejewski PL, Dannals RF, Wagner HN, Robinson RG (1990) Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Ann Neurol 26: 57–64CrossRefGoogle Scholar
  28. Mayeux R, Stern Y, Rosen J, Leventhal J (1981) Depression, intellectual impairment, and Parkinson’s disease. Neurology 31: 645–650PubMedCrossRefGoogle Scholar
  29. Mayeux R, Stern Y, Coté L, Williams JBW (1984) Altered serotonin metabolism in depressed patients with Parkinson’s disease. Neurology 34: 642–646PubMedCrossRefGoogle Scholar
  30. Mayeux, R, Stern Y, Sano M et al. (1988) The relationship of serotonin to depression in Parkinson’s disease. Mov Disord 3: 237–244PubMedCrossRefGoogle Scholar
  31. Menza MA, Forman NE, Goldstein HS et al. (1990) Parkinson’s disease, personality, and dopamine. J Neuropsychiatry Clin Neurosci 2: 282–287PubMedGoogle Scholar
  32. Menza M, Sage J, Marshall E, Cody R, Duvoisin R (1990) Mood changes and „on-off“ phenomena in Parkinson’s disease. Mov Disord 5: 148–151PubMedCrossRefGoogle Scholar
  33. Menza MA, Robertson-Hoffmann DE, Bonapace AS (1993) Parkinson’s disease and anxiety: comorbidity with depression. Biol Psychiatry 34: 465–470PubMedCrossRefGoogle Scholar
  34. Mindham RHS (1970) Psychiatric symptoms in parkinsonism. J Neurol Neurosurg Psychiatry 33: 188–191PubMedCrossRefGoogle Scholar
  35. Mindham RHS, Marsden CD, Parkes JD (1976) Psychiatric symptoms during L-dopa therapy for Parkinson’s disease and their relationship to physical disability. Psychol Med 6: 23–33PubMedCrossRefGoogle Scholar
  36. Patrick HT, Levy DM (1922) Parkinson’s disease. A clinical study of 148 cases. Arch Neurol 7: 711–720Google Scholar
  37. Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol 50: 743–755PubMedCrossRefGoogle Scholar
  38. Raisman R, Cash R, Agid Y (1986) Parkinson’s disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen. Neurology 36: 556–560PubMedCrossRefGoogle Scholar
  39. Ring HA, Bench CJ, Trimble MR, Brooks DJ, Frackowiak RSJ, Dolan RJ (1994) Depression in Parkinson’s disease. A positron emission study. Br J Psychiatry 165: 333–339Google Scholar
  40. Robins AH (1976) Depression in patients with Parkinson’s disease. Br J Psychiatry 128: 141–145PubMedCrossRefGoogle Scholar
  41. Sano M, Stanley M, Lawton L et al. (1990) 3H-Imipramine binding as a peripheral measure of serotonin in Parkinson’s disease. Neurology 40: 425Google Scholar
  42. Santamaria J, Tolosa E, Valles A (1986) A Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36: 1130–1133PubMedCrossRefGoogle Scholar
  43. Schiffer RB, Kurlan R, Rubin A, Boer S (1988) Evidence for atypical depression in Parkinson’s disease. Am J Psychiatry 145: 1020–1022PubMedGoogle Scholar
  44. Schildkraut JJ (1973) Neuropharmacology of the affective disorders. Ann Rev Pharmacol 13: 427–454PubMedCrossRefGoogle Scholar
  45. Stanley M, Virgilio J, Gershon S (1982) Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216: 1337–1339PubMedCrossRefGoogle Scholar
  46. Stanley M, Traskman-Bendz L, Dorovini-Zis K (1985) Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37: 1279–1286PubMedCrossRefGoogle Scholar
  47. Stein MB, Heuser IJ, Juncos JL, Uhde TE (1990) Anxiety disorders and Parkinson’s disease. Am J Psychiatry 147: 217–220PubMedGoogle Scholar
  48. Taylor AE, Saint-Cyr JA, Lang AE (1988) Idiopathic Parkinson’s disease: revised concepts of cognitive and affective status. Can J Neurol Sci 15: 106–113PubMedGoogle Scholar
  49. Van PRAAG HM (1982) Depression. Lancet ii: 1259–1264Google Scholar
  50. Van Praag HM, De Haan S (1979) Central serotonin metabolism and frequency of depression. Psychiatr Res 1: 219–224CrossRefGoogle Scholar
  51. Warburton JW (1967) Depressive symptons in Parkinson patients referred for thalamotomy. J Neurol Neurosurg Psychiatry 30: 368–370PubMedCrossRefGoogle Scholar
  52. Zweig RM, Jankel WR, Hedreen JC, Mayeux R (1989) The pedunculopontine nucleus in Parkinson’s disease. Ann Neurol 26: 41–46PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1999

Authors and Affiliations

  • K. W. Lange
  • G. Becker
  • T. Becker

There are no affiliations available

Personalised recommendations